Roche to buy Flatiron Health for $1.9 billion to expand cancer care portfolio

(Reuters) - Swiss drugmaker Roche Holding AG said on Thursday it would buy the rest of the privately held U.S. cancer data company Flatiron Health Inc for $1.9 billion to speed up development and delivery of breakthrough medicines for cancer patients.